Luminespib | m-entrepreneurship.com

Product Name :
Luminespib

Search keywords :
Luminespib

drugId :
null

Target Vo:
Heat shock protein HSP90

Target Vo Short Name :
HSP90

Moa_Name:
Heat shock protein HSP90 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Vernalis Plc

Active Company_Name :
Beijing Novartis Pharma Co Ltd

Active Indication_Name:
Adenocarcinoma of Lung

In Active Indication_Name:
Multiple Myeloma

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Loncastuximab Immunology/Inflammation
Caspase-5 p20 Antibody In stock
STAT1 Antibody (YA667): STAT1 Antibody (YA667) is a non-conjugated and Mouse origined monoclonal antibody about 87kDa, targeting to STAT1. It can be used for WB,ICC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts